Press Releases
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
1, June, 2024
Ultimovacs ASA Reports First Quarter 2024 Financial Results and Provides General Business Update
7, May, 2024
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24, April, 2024
See all
News
Interview with CEO Carlos de Sousa in Finansavisen TV
14, February, 2024
Biostock Article: About the NIPU study and interview with the Director of Medical Affairs at Ultimovacs, Espen Basmo Ellingsen
6, June, 2023
Ultimovacs Presentation at TD Cowen Healthcare Conference
6, March, 2023
Article published in Current Opinion in Oncology: “Therapeutic cancer vaccination against telomerase”
8, February, 2023
See all